{"schemaVersion":"ready-scan.discovery-entity.v3","id":"urn:readyscan:entity:catalyst-q139885826","slug":"catalyst-q139885826","kind":"entity","entityType":"Organization","canonicalUrl":"https://directory.readyscan.ai/entities/catalyst-q139885826","machineUrl":"https://directory.readyscan.ai/discovery/entities/catalyst-q139885826.json","llmsUrl":"https://directory.readyscan.ai/entities/catalyst-q139885826/llms.txt","name":"Catalyst","alternateNames":[],"websiteUrl":"https://catalystexplains.com/","category":{"slug":"businesses","name":"Businesses","canonicalUrl":"https://directory.readyscan.ai/directory/businesses"},"description":"Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics.","summary":"Catalyst: Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics. Website: https://catalystexplains.com.","localizedDescriptions":[],"claims":[{"id":"content-native-digital-agencies-bd8118dce10aa767-a-f5f83f29158d71ef08a4","label":"Where should I start?","value":"“Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.”","sourceIds":["source-record"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7e2dc8e987685701318e","label":"What is Science Explained?","value":"“Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.”","sourceIds":["source-record"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-11f46393954b2865c716","label":"What is Peptide News?","value":"“Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.”","sourceIds":["source-record"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-149afce15a225a8aed6c","label":"What is the GLP-3 Overview?","value":"“The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.”","sourceIds":["source-record"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-3c33d96996b850d01828","label":"What does “third generation” mean?","value":"“In Catalyst's GLP-3 coverage, third generation describes research built around three receptor pathways: GLP-1, GIP, and glucagon.”","sourceIds":["source-f76c27ae50ea232c"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7546100b22fa65a8c1ef","label":"Why do newer GLP compounds target more than one receptor?","value":"“Researchers are studying whether combining complementary metabolic signals can produce broader effects than targeting a single pathway alone.”","sourceIds":["source-f76c27ae50ea232c"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-1879eadd9be98c9d7c02","label":"Where can I go deeper?","value":"“Science Explained articles connect related guides and cited sources so readers can move from a plain-language introduction into the underlying research.”","sourceIds":["source-f76c27ae50ea232c"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-5a9e31bda2357834115b","label":"What is changing in the GLP market?","value":"“The category is moving from single-receptor medicines toward dual- and triple-receptor research, while new delivery formats, indications, and access models continue to develop.”","sourceIds":["source-f76c27ae50ea232c"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-6daeda7912fea6157cbd","label":"Where can I follow new GLP developments?","value":"“Peptide News covers current developments, while Science Explained provides the deeper background needed to understand why they matter.”","sourceIds":["source-f76c27ae50ea232c"]},{"id":"source-description","label":"About","value":"Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics.","sourceIds":["source-80a29ece4e89df82"]},{"id":"source-listed-website","label":"Website","value":"https://catalystexplains.com","sourceIds":["source-80a29ece4e89df82"]}],"knowledge":{"offerings":[],"answers":[{"id":"content-native-digital-agencies-bd8118dce10aa767-a-f5f83f29158d71ef08a4","question":"Where should I start?","answer":"“Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.”","sourceIds":["source-record"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-f5f83f29158d71ef08a4"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7e2dc8e987685701318e","question":"What is Science Explained?","answer":"“Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.”","sourceIds":["source-record"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-7e2dc8e987685701318e"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-11f46393954b2865c716","question":"What is Peptide News?","answer":"“Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.”","sourceIds":["source-record"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-11f46393954b2865c716"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-149afce15a225a8aed6c","question":"What is the GLP-3 Overview?","answer":"“The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.”","sourceIds":["source-record"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-149afce15a225a8aed6c"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-3c33d96996b850d01828","question":"What does “third generation” mean?","answer":"“In Catalyst's GLP-3 coverage, third generation describes research built around three receptor pathways: GLP-1, GIP, and glucagon.”","sourceIds":["source-f76c27ae50ea232c"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-3c33d96996b850d01828"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-7546100b22fa65a8c1ef","question":"Why do newer GLP compounds target more than one receptor?","answer":"“Researchers are studying whether combining complementary metabolic signals can produce broader effects than targeting a single pathway alone.”","sourceIds":["source-f76c27ae50ea232c"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-7546100b22fa65a8c1ef"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-1879eadd9be98c9d7c02","question":"Where can I go deeper?","answer":"“Science Explained articles connect related guides and cited sources so readers can move from a plain-language introduction into the underlying research.”","sourceIds":["source-f76c27ae50ea232c"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-1879eadd9be98c9d7c02"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-5a9e31bda2357834115b","question":"What is changing in the GLP market?","answer":"“The category is moving from single-receptor medicines toward dual- and triple-receptor research, while new delivery formats, indications, and access models continue to develop.”","sourceIds":["source-f76c27ae50ea232c"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-5a9e31bda2357834115b"]},{"id":"content-native-digital-agencies-bd8118dce10aa767-a-6daeda7912fea6157cbd","question":"Where can I follow new GLP developments?","answer":"“Peptide News covers current developments, while Science Explained provides the deeper background needed to understand why they matter.”","sourceIds":["source-f76c27ae50ea232c"],"claimIds":["content-native-digital-agencies-bd8118dce10aa767-a-6daeda7912fea6157cbd"]}],"developments":[]},"sources":[{"id":"source-record","title":"Catalyst website","publisher":"catalystexplains.com","url":"https://catalystexplains.com/","accessedOn":"2026-10-24","relatedPublicationsUrl":"https://readyscan.ai/sources/source-bd8118dce10aa767"},{"id":"source-f76c27ae50ea232c","title":"catalystexplains.com/faq/","publisher":"catalystexplains.com","url":"https://catalystexplains.com/faq/","accessedOn":"2026-10-24","relatedPublicationsUrl":"https://readyscan.ai/sources/source-f76c27ae50ea232c"},{"id":"source-80a29ece4e89df82","title":"wikidata.org/wiki/Special:EntityData/Q139885826.json","publisher":"wikidata.org","url":"https://www.wikidata.org/wiki/Special:EntityData/Q139885826.json?revision=2495847818","accessedOn":"2026-10-24","relatedPublicationsUrl":"https://readyscan.ai/sources/source-80a29ece4e89df82"}],"ownership":{"state":"public_sourced_unclaimed","notice":"Public-source record; owner verification is not claimed.","provenance":{"snapshotId":"catalyst-q139885826-content-710f9c4b1673a68c-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q139885826","sourceRevisionId":"Q139885826:content:47f2f3e6b3fbe436","sourceContentHash":"fnv1a64:2a332fa987a77f88","recordRevisionId":"Q139885826:content:47f2f3e6b3fbe436","recordContentHash":"fnv1a64:ecd3ba7bc72c029d","sourceCanonicalUrl":"https://catalystexplains.com/","sourceModifiedAt":"2026-10-24T05:35:55.461Z","observedOn":"2026-10-24","permission":{"basis":"public_information","evidenceUrl":"https://catalystexplains.com/"},"attributionUrl":"https://catalystexplains.com/"}},"datePublished":"2026-10-24","dateModified":"2026-10-24","contentFingerprint":"fnv1a64:8a619c8c91e2a26f","revision":"fnv1a64:2ddc4a1aaff528b5","agentProtocol":{"discovery":"https://readyscan.ai/api/v1/ai-search/discovery","evidence":"https://readyscan.ai/api/v1/ai-search/entities/catalyst-q139885826/evidence"},"structuredData":{"@context":"https://schema.org","@id":"https://directory.readyscan.ai/entities/catalyst-q139885826#entity","name":"Catalyst","identifier":"urn:readyscan:entity:catalyst-q139885826","description":"Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics.","url":"https://catalystexplains.com/","mainEntityOfPage":"https://directory.readyscan.ai/entities/catalyst-q139885826","datePublished":"2026-10-24","dateModified":"2026-10-24","citation":["https://catalystexplains.com/","https://catalystexplains.com/faq/","https://www.wikidata.org/wiki/Special:EntityData/Q139885826.json?revision=2495847818"],"additionalProperty":[{"@type":"PropertyValue","propertyID":"ownership-state","name":"Ownership state","value":"public_sourced_unclaimed"},{"@type":"PropertyValue","propertyID":"content-fingerprint","name":"Material content fingerprint","value":"fnv1a64:8a619c8c91e2a26f"},{"@type":"PropertyValue","propertyID":"source-record","name":"Source record","value":"ready-scan-subjects/Q139885826"},{"@type":"PropertyValue","propertyID":"source-revision","name":"Source revision","value":"Q139885826:content:47f2f3e6b3fbe436"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-f5f83f29158d71ef08a4","name":"Where should I start?","value":"“Start with Science Explained for foundational guides, Peptide News for current developments, or the GLP-3 Overview for a focused introduction to the next generation of GLP research.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-7e2dc8e987685701318e","name":"What is Science Explained?","value":"“Science Explained is a library of visual, plain-language guides to peptide biology, GLP mechanisms, myths, and the questions readers ask most.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-11f46393954b2865c716","name":"What is Peptide News?","value":"“Peptide News follows the research, companies, policy decisions, and market developments shaping the peptide category.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-149afce15a225a8aed6c","name":"What is the GLP-3 Overview?","value":"“The GLP-3 Overview is a focused introduction to triple-receptor research and how GLP-1, GIP, and glucagon pathways are studied together.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-3c33d96996b850d01828","name":"What does “third generation” mean?","value":"“In Catalyst's GLP-3 coverage, third generation describes research built around three receptor pathways: GLP-1, GIP, and glucagon.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-7546100b22fa65a8c1ef","name":"Why do newer GLP compounds target more than one receptor?","value":"“Researchers are studying whether combining complementary metabolic signals can produce broader effects than targeting a single pathway alone.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-1879eadd9be98c9d7c02","name":"Where can I go deeper?","value":"“Science Explained articles connect related guides and cited sources so readers can move from a plain-language introduction into the underlying research.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-5a9e31bda2357834115b","name":"What is changing in the GLP market?","value":"“The category is moving from single-receptor medicines toward dual- and triple-receptor research, while new delivery formats, indications, and access models continue to develop.”"},{"@type":"PropertyValue","propertyID":"claim:content-native-digital-agencies-bd8118dce10aa767-a-6daeda7912fea6157cbd","name":"Where can I follow new GLP developments?","value":"“Peptide News covers current developments, while Science Explained provides the deeper background needed to understand why they matter.”"},{"@type":"PropertyValue","propertyID":"claim:source-description","name":"About","value":"Houston-based U.S. company combining GLP-class peptide commerce with science-explainer publishing on peptide therapeutics."},{"@type":"PropertyValue","propertyID":"claim:source-listed-website","name":"Website","value":"https://catalystexplains.com"}],"@type":"Organization"}}